CUE
Cue Biopharma
25.90$
+1.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 89.0% | 93.0% | 97.2% | 89.5% | 85.2% | 87.9% | 82.1% | 84.6% | 83.6% | 78.1% | 87.6% | |
| 87.6% | 91.7% | 94.9% | 45.9% | 61.9% | 75.2% | 77.2% | 56.5% | 78.8% | 69.8% | 64.3% | |
| 88.3% | 92.0% | 95.0% | 86.4% | 83.0% | 85.3% | 77.2% | 83.6% | 78.8% | 69.8% | 64.3% | |
| – | – | 1.3% | – | 1.1% | 1.4% | 3.8% | 0.1% | 2.8% | 2.9% | 17.6% | |
| – | – | 0.3% | – | 21.1% | – | 0.0% | 0.0% | 0.0% | – | – | |
| 9.7% | 6.3% | 2.5% | 6.1% | 10.0% | 2.1% | 2.5% | 1.6% | – | – | – | |
| – | – | 0.3% | – | 0.0% | – | – | – | – | – | – | |
| 5.1% | 6.8% | 8.0% | 25.1% | 23.8% | 20.7% | 21.5% | 28.0% | 39.7% | 45.6% | 37.4% | |
| 4.7% | 6.6% | 8.0% | 13.7% | 16.3% | 16.4% | 15.3% | 12.7% | 27.8% | 42.5% | 32.0% | |
| – | – | 3.7% | – | 6.2% | 4.8% | 8.3% | 5.8% | 11.9% | 24.5% | 4.5% | |
| 1.9% | 3.2% | 2.0% | 4.5% | 1.2% | 2.1% | 3.1% | 3.0% | 5.7% | 8.8% | 9.4% | |
| – | – | – | – | – | – | – | 8.8% | 6.8% | – | – | |
| 94.9% | 93.2% | 92.0% | 74.9% | 76.2% | 79.3% | 78.5% | 72.0% | 60.3% | 54.4% | 62.6% | |
| -26.4% | -58.9% | -49.0% | -158.3% | -151.5% | -154.0% | -236.7% | -274.4% | -489.5% | -1,062.0% | -872.9% | |
| 3.4% | 4.2% | 1.0% | 1.5% | 1.0% | 1.0% | 1.3% | 1.3% | 2.5% | 5.8% | 7.5% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.